Delivery Order SPE2DB22D1017-SPE2DB26FYPHM
- Not listed
- The Defense Logistics Agency awarded a $4,741.86 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for Rytary ER 48.75 mg-195 mg capsules (100-count supply). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 6, 2025. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,844.36 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Rytary ER (carbidopa-levodopa extended-release) 36.25 mg-145 mg capsules in a quantity of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,559.33 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RYTARY ER 36.25 mg–145 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,025.48 on August 5, 2025, for the supply of Rytary ER 48.75 mg-195 mg capsules (100-count). The contract, which is non-set-aside and competitively awarded, utilizes firm fixed pricing and is scheduled for completion by August 6, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,241.31 to AmerisourceBergen Drug Corp for Rytary ER 36.25 mg–145 mg capsules (100-count supply) on June 5, 2025, with completion scheduled for June 6, 2025. This non-set-aside, firm fixed-price delivery order represents pharmaceutical procurement for military healthcare support. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and holds...
- The Defense Logistics Agency awarded a delivery order valued at $2,102.87 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg–195 mg capsules (100 count) on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $44,283.84 to AmerisourceBergen Drug Corp for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and was awarded on June 6, 2025 without any set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,742.38 to AmerisourceBergen Drug Corp for Rytary ER 48.75 mg-195 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Rytary is a carbidopa-levodopa extended-release medication used to treat Parkinson's disease...
- The Defense Logistics Agency awarded a delivery order valued at $13,679.70 to AmerisourceBergen Drug Corp for the supply of Rytary ER 36.25 mg-145 mg capsules (100 count) under a firm fixed price contract. This competitive award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $6,963.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Rytary ER 48.75 mg-195 mg capsules (100-count containers). This is a non-set-aside competitive award with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Rytary is a combination levodopa/carbidopa extended-release medication used to treat...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB26FYPHMDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,680.89 on October 17, 2025, for the supply of Rytary ER 36.25 mg-145 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and performance scheduled to be completed by October 20, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that supports pharmaceutical supply across military and federal healthcare systems globally. Rytary, a carbidopa-levodopa extended-release medication used in Parkinson's disease treatment, represents the type of specialized neurological pharmaceutical that AmerisourceBergen regularly provides through its DLA contracts to support Defense Health Agency operations and other government healthcare beneficiaries. The company's standing as a major federal pharmaceutical vendor is evidenced by its comprehensive portfolio of delivery orders spanning multiple therapeutic domains, including specialty medications, vaccines, and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 10/17/25 |